Nuvation Bio Inc.
NUVB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $715 | $331 | $416 | $1,682 |
| - Cash | $36 | $43 | $101 | $132 |
| + Debt | $9 | $4 | $4 | $3 |
| Enterprise Value | $688 | $292 | $319 | $1,553 |
| Revenue | $8 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 10.1% | – | – | – |
| EBITDA | -$567 | -$76 | -$120 | -$93 |
| % Margin | -7,200.7% | – | – | – |
| Net Income | -$568 | -$76 | -$104 | -$87 |
| % Margin | -7,213.8% | – | – | – |
| EPS Diluted | -2.11 | -0.35 | -0.48 | -0.44 |
| % Growth | -502.9% | 27.1% | -9.1% | – |
| Operating Cash Flow | -$130 | -$68 | -$96 | -$68 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$131 | -$68 | -$96 | -$68 |